tiprankstipranks
Immunotech Biopharm Ltd (HK:6978)
:6978
Hong Kong Market

Immunotech Biopharm Ltd (6978) Income Statement

Compare
0 Followers

Immunotech Biopharm Ltd Income Statement

Last quarter (Q2 2024), Immunotech Biopharm Ltd's total revenue was ¥0.00, a decrease of ― from the same quarter last year. In Q2, Immunotech Biopharm Ltd's net income was ¥-92.52K. See Immunotech Biopharm Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Gross Profit
¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Operating Expenses
¥ 230.55M¥ 268.83M¥ 335.59M¥ 383.23M¥ 110.86M
Depreciation and Amortization
¥ 52.22M¥ 44.07M¥ 21.00M¥ 13.78M¥ 10.95M
EBITDA
¥ -178.83M¥ -236.16M¥ -324.33M¥ -333.99M¥ -86.79M
Operating Income
¥ -230.55M¥ -280.24M¥ -333.35M¥ -419.83M¥ -110.14M
Other Income/Expenses
¥ -104.93M¥ -47.16M¥ -9.75M¥ -91.88M¥ -18.75M
Pretax Income
¥ -335.48M¥ -321.10M¥ -354.62M¥ -439.13M¥ -109.05M
Net Income
¥ -334.82M¥ -352.83M¥ -375.49M¥ -458.34M¥ -107.71M
Per Share Metrics
Basic EPS
¥ -0.65¥ -0.69¥ -0.73¥ -1.03¥ -0.22
Diluted EPS
¥ -0.65¥ -0.69¥ -0.73¥ -1.03¥ -0.22
Weighted Average Shares Outstanding
514.58M 514.58M 514.58M 443.81M 500.00M
Weighted Average Shares Outstanding (Diluted)
514.58M 514.58M 514.58M 443.81M 500.00M
Currency in CNY

Immunotech Biopharm Ltd Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis